Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis

NCT02794012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2018-01-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the association of Rheumatoid Arthritis (RA)-related antibodies and periodontal inflammation in subjects at-risk for Rheumatoid Arthritis. Subjects will undergo periodontal and joint examinations, as well as collection of body fluids to measure Rheumatoid Arthritis-related antibodies.

Conditions

Sponsors & Collaborators

  • Rheumatology Research Foundation

    collaborator OTHER
  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Lindsay B Kelmenson, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794012 on ClinicalTrials.gov